Table 2.
Serum Ceramides (nmol/L) of individuals among the three groups
| NW | OB | |||
|---|---|---|---|---|
| NC (n = 21) | MHO (n = 20) | MUO (n = 36) | P | |
| Cer d18:0/18:0 | 245.1 (132.4,349.6) | 105.2 (90.3,217.9)a | 152.8 (108.7,265.3) | 0.015 |
| Cer d18:0/24:1 | 165.9 (116.8,352.7) | 135.5 (87.5,225.4) | 131.4 (95.0,223.0) | 0.308 |
| Cer d18:1/16:0 | 740.9 (649.9,994.9) | 559.2 (462.5,710.3)a | 616.1 (545.4,829.2) | 0.028 |
| Cer d18:1/18:0 | 451.4 (223.4,559.3) | 284.8 (232.1,380.0) | 328.6 (233.8,458.3) | 0.531 |
| Cer d18:1/20:0 | 247.0 (114.6,394.4) | 209.4 (158.5,250.3) | 250.7 (158.6,452.0) | 0.25 |
| Cer d18:1/22:0 | 785.5 (519.9,981.2) | 895.6 (753.0,1240.0) | 1147.5 (824.3,1464.1)a | 0.003 |
| Cer d18:1/24:1 | 1600.1 (1013.9,2078.8) | 1582.3 (1310.7,1969.0) | 2201.4 (1676.2,2923.4)ab | ＜0.001 |
| Cer d18:1/24:0 | 2123.8 (1700.9,3391.0) | 2680.4 (2048.0,3895.3) | 3287.5 (2396.1,4505.9)a | 0.025 |
| Cer | 7181.1 (5121.9,7926.6) | 6326.1 (5563.2,8312.3) | 8271.9 (6784.7,10703.3)ab | 0.009 |
The concentration values of ceramides were transformed into a normal distribution by logarithm
The concentrations of ceramides among the three groups were compared via one-way ANOVA with Bonferroni correction
Continuous variables that were not normally distributed were presented as median (quartile1, quartile3)
a Significant differences (P < 0.05) were shown with the NC group through post hoc tests. b Significant differences (P < 0.05) were shown with MHO through post hoc tests